Nuvectis Pharma (NVCT)
(Delayed Data from NSDQ)
$6.40 USD
-0.27 (-4.05%)
Updated Sep 16, 2024 04:00 PM ET
After-Market: $6.40 0.00 (0.00%) 5:50 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.26 | 0.00% |
Earnings Summary
For their last quarter, Nuvectis Pharma (NVCT) reported earnings of -$0.26 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for NVCT's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.26 per share, reflecting a year-over-year increase of 29.73%.
Earnings History
Price & Consensus
Zacks News for NVCT
Down -36.49% in 4 Weeks, Here's Why You Should You Buy the Dip in Nuvectis Pharma, Inc. (NVCT)
NVCT: What are Zacks experts saying now?
Zacks Private Portfolio Services